Delaware

Delaware Law360 provides breaking news and analysis on legal and regulatory issues in Delaware. Coverage includes high-stakes litigation, policy developments, and corporate deals affecting the state.



Sign up for a 7-day FREE trial today!



Latest News in Delaware

  • July 08, 2026

    Samsung Accuses Netlist Of Patent 'Double-Dip' In Latest Suit

    Samsung has kicked off yet another lawsuit in its long-running intellectual property dispute with Netlist, this time claiming that Netlist is trying to "double dip" with a demand that Samsung take a second license to Netlist's patents covering semiconductor technology, according to a complaint filed in Delaware federal court Wednesday.

  • July 08, 2026

    Amazon Ordered To Give FTC Docs It Claimed Were Privileged

    A Washington federal judge ordered Amazon to give the Federal Trade Commission several documents sought in the agency's antitrust case and said a "re-review" of the online retailer's discovery is needed to ensure the company "does not continue to withhold documents based on an improper application of the attorney-client privilege."

  • July 08, 2026

    3rd Circ. Wonders If Pipeline Approval Passed CWA Muster

    The Third Circuit on Wednesday pressed New Jersey's environmental regulator to show that the revived Northeast Supply Enhancement pipeline plan complied with the Clean Water Act, considering it lacked details about how state water quality standards would be monitored.

  • July 08, 2026

    Split 3rd Circ. Revives UPMC Doc's Suit Over Anti-DEI Article

    The Third Circuit partly revived a University of Pittsburgh Medical Center cardiologist's lawsuit over the professional backlash he faced for publishing an article criticizing race-based "affirmative action" in choosing medical students, with the court majority calling his bosses' reaction a defamatory "hit job."

  • July 08, 2026

    Handa, Intas Face Patent Suits Over Exelixis Cancer Drug

    Handa Pharmaceuticals and Intas Pharmaceuticals are wrongly trying to bring to market drugs that would compete with Exelixis Inc.'s blockbuster cancer pill Cabometyx before patents on the medication expire, according to a new lawsuit in Delaware federal court.

See more Delaware news

Delaware

Areas of Coverage

  • LITIGATION
  • Court of Chancery cases
  • Antitrust litigation
  • Class actions
  • Environmental suits
  • Labor and employment issues
  • Intellectual property cases
  • Product liability and consumer protection disputes
  • Securities disputes
  • Bankruptcy proceedings
  • AGENCIES
  • Federal Trade Commission
  • U.S. Consumer Product Safety Commission
  • U.S. Department of Justice
  • U.S. Department of Labor
  • U.S. Environmental Protection Agency
  • U.S. Food and Drug Administration
  • U.S. Patent and Trademark Office
  • U.S. Securities and Exchange Commission
  • Delaware Attorney General’s Office
  • ENFORCEMENT
  • Investigations and enforcement actions by state and federal prosecutors
  • TRANSACTIONS
  • Mergers, acquisitions, and joint ventures involving companies headquartered in Delaware
  • Real estate deals
  • PROFILES
  • Nominations, appointments, and elections of judges and agency officials in Delaware
  • Personnel moves
  • Profiles of Delaware judges, litigators, and firms

Readership

  • Lawyers at top law firms practicing in Delaware
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys working with Delaware-based companies
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals